nodes	percent_of_prediction	percent_of_DWPC	metapath
Dexbrompheniramine—Mepyramine—Rosiglitazone—type 2 diabetes mellitus	0.407	0.418	CrCrCtD
Dexbrompheniramine—Chloropyramine—Rosiglitazone—type 2 diabetes mellitus	0.365	0.376	CrCrCtD
Dexbrompheniramine—Tripelennamine—Rosiglitazone—type 2 diabetes mellitus	0.2	0.206	CrCrCtD
Dexbrompheniramine—Captodiame—HTR2C—type 2 diabetes mellitus	0.000861	0.233	CrCbGaD
Dexbrompheniramine—Carbinoxamine—CYP2E1—type 2 diabetes mellitus	0.000362	0.0978	CrCbGaD
Dexbrompheniramine—Brompheniramine—CYP2E1—type 2 diabetes mellitus	0.000314	0.0847	CrCbGaD
Dexbrompheniramine—Tolterodine—CYP3A4—type 2 diabetes mellitus	0.000266	0.0718	CrCbGaD
Dexbrompheniramine—Promazine—ADRA2A—type 2 diabetes mellitus	0.000247	0.0667	CrCbGaD
Dexbrompheniramine—Carbinoxamine—CYP3A4—type 2 diabetes mellitus	0.000228	0.0616	CrCbGaD
Dexbrompheniramine—Promazine—HTR2C—type 2 diabetes mellitus	0.000227	0.0614	CrCbGaD
Dexbrompheniramine—Diphenhydramine—CYP1A2—type 2 diabetes mellitus	0.000199	0.0537	CrCbGaD
Dexbrompheniramine—Orphenadrine—CYP2E1—type 2 diabetes mellitus	0.000198	0.0534	CrCbGaD
Dexbrompheniramine—Brompheniramine—CYP3A4—type 2 diabetes mellitus	0.000198	0.0534	CrCbGaD
Dexbrompheniramine—Chlorphenamine—CYP3A4—type 2 diabetes mellitus	0.000194	0.0524	CrCbGaD
Dexbrompheniramine—Promazine—CYP1A2—type 2 diabetes mellitus	0.000171	0.0463	CrCbGaD
Dexbrompheniramine—HRH1—IL-4 Signaling Pathway—IRS2—type 2 diabetes mellitus	0.000153	0.00641	CbGpPWpGaD
Dexbrompheniramine—HRH1—IL-4 Signaling Pathway—IRS1—type 2 diabetes mellitus	0.000134	0.0056	CbGpPWpGaD
Dexbrompheniramine—HRH1—GPCRs, Class A Rhodopsin-like—MC4R—type 2 diabetes mellitus	0.000133	0.00559	CbGpPWpGaD
Dexbrompheniramine—KCNH2—SIDS Susceptibility Pathways—NR3C1—type 2 diabetes mellitus	0.000133	0.00559	CbGpPWpGaD
Dexbrompheniramine—KCNH2—Hematopoietic Stem Cell Differentiation—IL6—type 2 diabetes mellitus	0.000131	0.00551	CbGpPWpGaD
Dexbrompheniramine—KCNH2—Neuronal System—SNAP25—type 2 diabetes mellitus	0.000131	0.00547	CbGpPWpGaD
Dexbrompheniramine—Orphenadrine—CYP3A4—type 2 diabetes mellitus	0.000124	0.0336	CrCbGaD
Dexbrompheniramine—KCNH2—SIDS Susceptibility Pathways—HIF1A—type 2 diabetes mellitus	0.000121	0.00509	CbGpPWpGaD
Dexbrompheniramine—HRH1—GPCR ligand binding—MTNR1A—type 2 diabetes mellitus	0.00012	0.00502	CbGpPWpGaD
Dexbrompheniramine—HRH1—G alpha (q) signalling events—CCKAR—type 2 diabetes mellitus	0.00012	0.00501	CbGpPWpGaD
Dexbrompheniramine—HRH1—Class A/1 (Rhodopsin-like receptors)—MC4R—type 2 diabetes mellitus	0.000114	0.00479	CbGpPWpGaD
Dexbrompheniramine—Promazine—CYP3A4—type 2 diabetes mellitus	0.000113	0.0307	CrCbGaD
Dexbrompheniramine—HRH1—IL-4 Signaling Pathway—PIK3R1—type 2 diabetes mellitus	0.000112	0.0047	CbGpPWpGaD
Dexbrompheniramine—HRH1—GPCRs, Class A Rhodopsin-like—ADRB3—type 2 diabetes mellitus	0.000109	0.00458	CbGpPWpGaD
Dexbrompheniramine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—CCKAR—type 2 diabetes mellitus	0.000107	0.00448	CbGpPWpGaD
Dexbrompheniramine—HRH1—IL-4 Signaling Pathway—RELA—type 2 diabetes mellitus	0.000106	0.00443	CbGpPWpGaD
Dexbrompheniramine—HRH1—G alpha (q) signalling events—TRPC6—type 2 diabetes mellitus	0.000105	0.00441	CbGpPWpGaD
Dexbrompheniramine—HRH1—GPCR ligand binding—GCGR—type 2 diabetes mellitus	0.000103	0.00433	CbGpPWpGaD
Dexbrompheniramine—HRH1—G alpha (q) signalling events—EDNRB—type 2 diabetes mellitus	0.0001	0.0042	CbGpPWpGaD
Dexbrompheniramine—KCNH2—Neuronal System—GNB3—type 2 diabetes mellitus	9.76e-05	0.00409	CbGpPWpGaD
Dexbrompheniramine—HRH1—G alpha (q) signalling events—HTR2C—type 2 diabetes mellitus	9.73e-05	0.00407	CbGpPWpGaD
Dexbrompheniramine—HRH1—GPCRs, Class A Rhodopsin-like—MTNR1B—type 2 diabetes mellitus	9.65e-05	0.00404	CbGpPWpGaD
Dexbrompheniramine—HRH1—GPCR ligand binding—GIPR—type 2 diabetes mellitus	9.52e-05	0.00399	CbGpPWpGaD
Dexbrompheniramine—HRH1—G alpha (q) signalling events—EDNRA—type 2 diabetes mellitus	9.46e-05	0.00396	CbGpPWpGaD
Dexbrompheniramine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—TRPC6—type 2 diabetes mellitus	9.41e-05	0.00394	CbGpPWpGaD
Dexbrompheniramine—HRH1—Class A/1 (Rhodopsin-like receptors)—ADRB3—type 2 diabetes mellitus	9.36e-05	0.00392	CbGpPWpGaD
Dexbrompheniramine—HRH1—GPCRs, Class A Rhodopsin-like—CCKAR—type 2 diabetes mellitus	9.25e-05	0.00388	CbGpPWpGaD
Dexbrompheniramine—HRH1—G alpha (q) signalling events—GHRL—type 2 diabetes mellitus	9.22e-05	0.00386	CbGpPWpGaD
Dexbrompheniramine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—EDNRB—type 2 diabetes mellitus	8.96e-05	0.00375	CbGpPWpGaD
Dexbrompheniramine—HRH1—IL-4 Signaling Pathway—NFKB1—type 2 diabetes mellitus	8.91e-05	0.00373	CbGpPWpGaD
Dexbrompheniramine—HRH1—GPCR ligand binding—MC4R—type 2 diabetes mellitus	8.71e-05	0.00365	CbGpPWpGaD
Dexbrompheniramine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2C—type 2 diabetes mellitus	8.7e-05	0.00364	CbGpPWpGaD
Dexbrompheniramine—KCNH2—Neuronal System—ADCY5—type 2 diabetes mellitus	8.7e-05	0.00364	CbGpPWpGaD
Dexbrompheniramine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—EDNRA—type 2 diabetes mellitus	8.46e-05	0.00354	CbGpPWpGaD
Dexbrompheniramine—HRH1—G alpha (q) signalling events—GCG—type 2 diabetes mellitus	8.43e-05	0.00353	CbGpPWpGaD
Dexbrompheniramine—HRH1—GPCR ligand binding—GIP—type 2 diabetes mellitus	8.38e-05	0.00351	CbGpPWpGaD
Dexbrompheniramine—HRH1—G alpha (q) signalling events—RASGRP1—type 2 diabetes mellitus	8.3e-05	0.00348	CbGpPWpGaD
Dexbrompheniramine—HRH1—Class A/1 (Rhodopsin-like receptors)—MTNR1B—type 2 diabetes mellitus	8.27e-05	0.00346	CbGpPWpGaD
Dexbrompheniramine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—GHRL—type 2 diabetes mellitus	8.25e-05	0.00345	CbGpPWpGaD
Dexbrompheniramine—HRH1—GPCRs, Class A Rhodopsin-like—AGTR2—type 2 diabetes mellitus	8.09e-05	0.00339	CbGpPWpGaD
Dexbrompheniramine—HRH1—Class A/1 (Rhodopsin-like receptors)—CCKAR—type 2 diabetes mellitus	7.93e-05	0.00332	CbGpPWpGaD
Dexbrompheniramine—HRH1—GPCRs, Class A Rhodopsin-like—EDNRB—type 2 diabetes mellitus	7.74e-05	0.00324	CbGpPWpGaD
Dexbrompheniramine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—GCG—type 2 diabetes mellitus	7.54e-05	0.00316	CbGpPWpGaD
Dexbrompheniramine—KCNH2—SIDS Susceptibility Pathways—CASP3—type 2 diabetes mellitus	7.54e-05	0.00316	CbGpPWpGaD
Dexbrompheniramine—HRH1—GPCRs, Class A Rhodopsin-like—HTR2C—type 2 diabetes mellitus	7.52e-05	0.00315	CbGpPWpGaD
Dexbrompheniramine—KCNH2—Neuronal System—CALM1—type 2 diabetes mellitus	7.47e-05	0.00313	CbGpPWpGaD
Dexbrompheniramine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—RASGRP1—type 2 diabetes mellitus	7.42e-05	0.00311	CbGpPWpGaD
Dexbrompheniramine—HRH1—GPCRs, Class A Rhodopsin-like—EDNRA—type 2 diabetes mellitus	7.31e-05	0.00306	CbGpPWpGaD
Dexbrompheniramine—HRH1—G alpha (q) signalling events—GNB3—type 2 diabetes mellitus	7.27e-05	0.00304	CbGpPWpGaD
Dexbrompheniramine—HRH1—G alpha (q) signalling events—AVP—type 2 diabetes mellitus	7.17e-05	0.003	CbGpPWpGaD
Dexbrompheniramine—HRH1—GPCRs, Class A Rhodopsin-like—ADRA2A—type 2 diabetes mellitus	7.16e-05	0.003	CbGpPWpGaD
Dexbrompheniramine—HRH1—GPCR ligand binding—ADRB3—type 2 diabetes mellitus	7.13e-05	0.00299	CbGpPWpGaD
Dexbrompheniramine—KCNH2—SIDS Susceptibility Pathways—NFKB1—type 2 diabetes mellitus	7.05e-05	0.00295	CbGpPWpGaD
Dexbrompheniramine—KCNH2—Neuronal System—PRKCB—type 2 diabetes mellitus	7.02e-05	0.00294	CbGpPWpGaD
Dexbrompheniramine—HRH1—Class A/1 (Rhodopsin-like receptors)—AGTR2—type 2 diabetes mellitus	6.93e-05	0.0029	CbGpPWpGaD
Dexbrompheniramine—HRH1—GPCR ligand binding—CRHR1—type 2 diabetes mellitus	6.88e-05	0.00288	CbGpPWpGaD
Dexbrompheniramine—HRH1—G alpha (q) signalling events—EDN1—type 2 diabetes mellitus	6.82e-05	0.00286	CbGpPWpGaD
Dexbrompheniramine—HRH1—GPCR downstream signaling—MTNR1A—type 2 diabetes mellitus	6.77e-05	0.00284	CbGpPWpGaD
Dexbrompheniramine—HRH1—Class A/1 (Rhodopsin-like receptors)—EDNRB—type 2 diabetes mellitus	6.63e-05	0.00278	CbGpPWpGaD
Dexbrompheniramine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—GNB3—type 2 diabetes mellitus	6.5e-05	0.00272	CbGpPWpGaD
Dexbrompheniramine—HRH1—Class A/1 (Rhodopsin-like receptors)—HTR2C—type 2 diabetes mellitus	6.44e-05	0.0027	CbGpPWpGaD
Dexbrompheniramine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—AVP—type 2 diabetes mellitus	6.41e-05	0.00269	CbGpPWpGaD
Dexbrompheniramine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—MMP3—type 2 diabetes mellitus	6.41e-05	0.00269	CbGpPWpGaD
Dexbrompheniramine—KCNH2—SIDS Susceptibility Pathways—VEGFA—type 2 diabetes mellitus	6.4e-05	0.00268	CbGpPWpGaD
Dexbrompheniramine—HRH1—GPCR ligand binding—MTNR1B—type 2 diabetes mellitus	6.3e-05	0.00264	CbGpPWpGaD
Dexbrompheniramine—HRH1—Class A/1 (Rhodopsin-like receptors)—EDNRA—type 2 diabetes mellitus	6.27e-05	0.00262	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling by GPCR—MTNR1A—type 2 diabetes mellitus	6.15e-05	0.00258	CbGpPWpGaD
Dexbrompheniramine—HRH1—GPCR ligand binding—GLP1R—type 2 diabetes mellitus	6.14e-05	0.00257	CbGpPWpGaD
Dexbrompheniramine—HRH1—Class A/1 (Rhodopsin-like receptors)—ADRA2A—type 2 diabetes mellitus	6.13e-05	0.00257	CbGpPWpGaD
Dexbrompheniramine—HRH1—Class A/1 (Rhodopsin-like receptors)—GHRL—type 2 diabetes mellitus	6.11e-05	0.00256	CbGpPWpGaD
Dexbrompheniramine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—EDN1—type 2 diabetes mellitus	6.1e-05	0.00256	CbGpPWpGaD
Dexbrompheniramine—HRH1—GPCR ligand binding—CCKAR—type 2 diabetes mellitus	6.04e-05	0.00253	CbGpPWpGaD
Dexbrompheniramine—HRH1—GPCR downstream signaling—GCGR—type 2 diabetes mellitus	5.85e-05	0.00245	CbGpPWpGaD
Dexbrompheniramine—HRH1—G alpha (q) signalling events—AGT—type 2 diabetes mellitus	5.66e-05	0.00237	CbGpPWpGaD
Dexbrompheniramine—KCNH2—SIDS Susceptibility Pathways—TNF—type 2 diabetes mellitus	5.48e-05	0.0023	CbGpPWpGaD
Dexbrompheniramine—HRH1—GPCR ligand binding—IAPP—type 2 diabetes mellitus	5.43e-05	0.00228	CbGpPWpGaD
Dexbrompheniramine—HRH1—GPCR downstream signaling—GRK5—type 2 diabetes mellitus	5.38e-05	0.00225	CbGpPWpGaD
Dexbrompheniramine—HRH1—GPCR downstream signaling—GIPR—type 2 diabetes mellitus	5.38e-05	0.00225	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling by GPCR—GCGR—type 2 diabetes mellitus	5.31e-05	0.00222	CbGpPWpGaD
Dexbrompheniramine—HRH1—GPCR ligand binding—AGTR2—type 2 diabetes mellitus	5.28e-05	0.00221	CbGpPWpGaD
Dexbrompheniramine—HRH1—IL-4 Signaling Pathway—AKT1—type 2 diabetes mellitus	5.16e-05	0.00216	CbGpPWpGaD
Dexbrompheniramine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—AGT—type 2 diabetes mellitus	5.06e-05	0.00212	CbGpPWpGaD
Dexbrompheniramine—HRH1—GPCR ligand binding—EDNRB—type 2 diabetes mellitus	5.05e-05	0.00212	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling Pathways—ARAP1—type 2 diabetes mellitus	5.03e-05	0.00211	CbGpPWpGaD
Dexbrompheniramine—HRH1—GPCR downstream signaling—MC4R—type 2 diabetes mellitus	4.92e-05	0.00206	CbGpPWpGaD
Dexbrompheniramine—HRH1—GPCR ligand binding—HTR2C—type 2 diabetes mellitus	4.9e-05	0.00205	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling by GPCR—GRK5—type 2 diabetes mellitus	4.89e-05	0.00205	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling by GPCR—GIPR—type 2 diabetes mellitus	4.89e-05	0.00205	CbGpPWpGaD
Dexbrompheniramine—HRH1—GPCR ligand binding—EDNRA—type 2 diabetes mellitus	4.77e-05	0.002	CbGpPWpGaD
Dexbrompheniramine—HRH1—Class A/1 (Rhodopsin-like receptors)—AVP—type 2 diabetes mellitus	4.75e-05	0.00199	CbGpPWpGaD
Dexbrompheniramine—HRH1—GPCR downstream signaling—GIP—type 2 diabetes mellitus	4.74e-05	0.00198	CbGpPWpGaD
Dexbrompheniramine—HRH1—GPCRs, Class A Rhodopsin-like—CCR5—type 2 diabetes mellitus	4.71e-05	0.00197	CbGpPWpGaD
Dexbrompheniramine—HRH1—GPCR ligand binding—ADRA2A—type 2 diabetes mellitus	4.67e-05	0.00196	CbGpPWpGaD
Dexbrompheniramine—HRH1—GPCR ligand binding—GHRL—type 2 diabetes mellitus	4.65e-05	0.00195	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling Pathways—VPS26A—type 2 diabetes mellitus	4.6e-05	0.00193	CbGpPWpGaD
Dexbrompheniramine—HRH1—GPCR ligand binding—CALCA—type 2 diabetes mellitus	4.59e-05	0.00192	CbGpPWpGaD
Dexbrompheniramine—HRH1—Class A/1 (Rhodopsin-like receptors)—EDN1—type 2 diabetes mellitus	4.52e-05	0.00189	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling by GPCR—MC4R—type 2 diabetes mellitus	4.47e-05	0.00187	CbGpPWpGaD
Dexbrompheniramine—KCNH2—SIDS Susceptibility Pathways—IL6—type 2 diabetes mellitus	4.43e-05	0.00185	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling by GPCR—GIP—type 2 diabetes mellitus	4.3e-05	0.0018	CbGpPWpGaD
Dexbrompheniramine—HRH1—GPCR ligand binding—GCG—type 2 diabetes mellitus	4.25e-05	0.00178	CbGpPWpGaD
Dexbrompheniramine—HRH1—G alpha (q) signalling events—PIK3R1—type 2 diabetes mellitus	4.16e-05	0.00174	CbGpPWpGaD
Dexbrompheniramine—HRH1—Class A/1 (Rhodopsin-like receptors)—CCR5—type 2 diabetes mellitus	4.04e-05	0.00169	CbGpPWpGaD
Dexbrompheniramine—HRH1—GPCR downstream signaling—ADRB3—type 2 diabetes mellitus	4.03e-05	0.00169	CbGpPWpGaD
Dexbrompheniramine—HRH1—Class A/1 (Rhodopsin-like receptors)—C3—type 2 diabetes mellitus	3.95e-05	0.00165	CbGpPWpGaD
Dexbrompheniramine—HRH1—GPCR downstream signaling—CRHR1—type 2 diabetes mellitus	3.89e-05	0.00163	CbGpPWpGaD
Dexbrompheniramine—HRH1—Class A/1 (Rhodopsin-like receptors)—AGT—type 2 diabetes mellitus	3.75e-05	0.00157	CbGpPWpGaD
Dexbrompheniramine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3R1—type 2 diabetes mellitus	3.72e-05	0.00156	CbGpPWpGaD
Dexbrompheniramine—HRH1—GPCR ligand binding—GNB3—type 2 diabetes mellitus	3.67e-05	0.00154	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling by GPCR—ADRB3—type 2 diabetes mellitus	3.66e-05	0.00153	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling Pathways—MTNR1A—type 2 diabetes mellitus	3.63e-05	0.00152	CbGpPWpGaD
Dexbrompheniramine—HRH1—GPCR ligand binding—AVP—type 2 diabetes mellitus	3.62e-05	0.00151	CbGpPWpGaD
Dexbrompheniramine—HRH1—GPCR downstream signaling—MTNR1B—type 2 diabetes mellitus	3.56e-05	0.00149	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling by GPCR—CRHR1—type 2 diabetes mellitus	3.53e-05	0.00148	CbGpPWpGaD
Dexbrompheniramine—HRH1—GPCR downstream signaling—GLP1R—type 2 diabetes mellitus	3.47e-05	0.00145	CbGpPWpGaD
Dexbrompheniramine—HRH1—GPCR ligand binding—EDN1—type 2 diabetes mellitus	3.44e-05	0.00144	CbGpPWpGaD
Dexbrompheniramine—HRH1—GPCR downstream signaling—CCKAR—type 2 diabetes mellitus	3.41e-05	0.00143	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling by GPCR—MTNR1B—type 2 diabetes mellitus	3.23e-05	0.00135	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling by GPCR—GLP1R—type 2 diabetes mellitus	3.15e-05	0.00132	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling Pathways—GCGR—type 2 diabetes mellitus	3.14e-05	0.00131	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling by GPCR—CCKAR—type 2 diabetes mellitus	3.1e-05	0.0013	CbGpPWpGaD
Dexbrompheniramine—HRH1—Class A/1 (Rhodopsin-like receptors)—CCL2—type 2 diabetes mellitus	3.09e-05	0.00129	CbGpPWpGaD
Dexbrompheniramine—HRH1—GPCR ligand binding—CCR5—type 2 diabetes mellitus	3.07e-05	0.00129	CbGpPWpGaD
Dexbrompheniramine—HRH1—GPCR downstream signaling—IAPP—type 2 diabetes mellitus	3.07e-05	0.00129	CbGpPWpGaD
Dexbrompheniramine—HRH1—GPCR ligand binding—C3—type 2 diabetes mellitus	3e-05	0.00126	CbGpPWpGaD
Dexbrompheniramine—HRH1—GPCR downstream signaling—TRPC6—type 2 diabetes mellitus	3e-05	0.00126	CbGpPWpGaD
Dexbrompheniramine—HRH1—GPCR downstream signaling—AGTR2—type 2 diabetes mellitus	2.98e-05	0.00125	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling Pathways—GIPR—type 2 diabetes mellitus	2.89e-05	0.00121	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling Pathways—GRK5—type 2 diabetes mellitus	2.89e-05	0.00121	CbGpPWpGaD
Dexbrompheniramine—HRH1—GPCR downstream signaling—EDNRB—type 2 diabetes mellitus	2.86e-05	0.0012	CbGpPWpGaD
Dexbrompheniramine—HRH1—GPCR ligand binding—AGT—type 2 diabetes mellitus	2.85e-05	0.0012	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling by GPCR—IAPP—type 2 diabetes mellitus	2.79e-05	0.00117	CbGpPWpGaD
Dexbrompheniramine—HRH1—GPCR downstream signaling—HTR2C—type 2 diabetes mellitus	2.77e-05	0.00116	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling by GPCR—TRPC6—type 2 diabetes mellitus	2.72e-05	0.00114	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling by GPCR—AGTR2—type 2 diabetes mellitus	2.71e-05	0.00113	CbGpPWpGaD
Dexbrompheniramine—HRH1—GPCR downstream signaling—EDNRA—type 2 diabetes mellitus	2.7e-05	0.00113	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling Pathways—MC4R—type 2 diabetes mellitus	2.64e-05	0.00111	CbGpPWpGaD
Dexbrompheniramine—HRH1—GPCR downstream signaling—ADRA2A—type 2 diabetes mellitus	2.64e-05	0.00111	CbGpPWpGaD
Dexbrompheniramine—HRH1—GPCR downstream signaling—GHRL—type 2 diabetes mellitus	2.63e-05	0.0011	CbGpPWpGaD
Dexbrompheniramine—HRH1—GPCR downstream signaling—CALCA—type 2 diabetes mellitus	2.6e-05	0.00109	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling by GPCR—EDNRB—type 2 diabetes mellitus	2.59e-05	0.00109	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling Pathways—GIP—type 2 diabetes mellitus	2.54e-05	0.00106	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling by GPCR—HTR2C—type 2 diabetes mellitus	2.52e-05	0.00105	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling by GPCR—EDNRA—type 2 diabetes mellitus	2.45e-05	0.00103	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling Pathways—LEPR—type 2 diabetes mellitus	2.41e-05	0.00101	CbGpPWpGaD
Dexbrompheniramine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—type 2 diabetes mellitus	2.41e-05	0.00101	CbGpPWpGaD
Dexbrompheniramine—HRH1—GPCR downstream signaling—GCG—type 2 diabetes mellitus	2.4e-05	0.00101	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling by GPCR—ADRA2A—type 2 diabetes mellitus	2.4e-05	0.001	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling by GPCR—GHRL—type 2 diabetes mellitus	2.39e-05	0.001	CbGpPWpGaD
Dexbrompheniramine—HRH1—GPCR downstream signaling—RASGRP1—type 2 diabetes mellitus	2.36e-05	0.00099	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling by GPCR—CALCA—type 2 diabetes mellitus	2.36e-05	0.000987	CbGpPWpGaD
Dexbrompheniramine—HRH1—GPCR ligand binding—CCL2—type 2 diabetes mellitus	2.35e-05	0.000985	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling Pathways—ATP2A3—type 2 diabetes mellitus	2.31e-05	0.000967	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling Pathways—TLE4—type 2 diabetes mellitus	2.24e-05	0.00094	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling by GPCR—GCG—type 2 diabetes mellitus	2.18e-05	0.000914	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling Pathways—ADRB3—type 2 diabetes mellitus	2.16e-05	0.000905	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling by GPCR—RASGRP1—type 2 diabetes mellitus	2.15e-05	0.000899	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling Pathways—CRHR1—type 2 diabetes mellitus	2.09e-05	0.000874	CbGpPWpGaD
Dexbrompheniramine—HRH1—GPCR downstream signaling—GNB3—type 2 diabetes mellitus	2.07e-05	0.000868	CbGpPWpGaD
Dexbrompheniramine—HRH1—GPCR downstream signaling—AVP—type 2 diabetes mellitus	2.04e-05	0.000856	CbGpPWpGaD
Dexbrompheniramine—HRH1—GPCR downstream signaling—EDN1—type 2 diabetes mellitus	1.94e-05	0.000814	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling Pathways—PRKAA1—type 2 diabetes mellitus	1.93e-05	0.000807	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling Pathways—MTNR1B—type 2 diabetes mellitus	1.91e-05	0.0008	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling Pathways—SPRY2—type 2 diabetes mellitus	1.91e-05	0.0008	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling by GPCR—GNB3—type 2 diabetes mellitus	1.88e-05	0.000788	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling Pathways—GLP1R—type 2 diabetes mellitus	1.86e-05	0.000779	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling Pathways—RBP4—type 2 diabetes mellitus	1.86e-05	0.000779	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling by GPCR—AVP—type 2 diabetes mellitus	1.86e-05	0.000777	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling by GPCR—MMP3—type 2 diabetes mellitus	1.86e-05	0.000777	CbGpPWpGaD
Dexbrompheniramine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—type 2 diabetes mellitus	1.85e-05	0.000776	CbGpPWpGaD
Dexbrompheniramine—HRH1—GPCR downstream signaling—ADCY5—type 2 diabetes mellitus	1.85e-05	0.000773	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling Pathways—CCKAR—type 2 diabetes mellitus	1.83e-05	0.000767	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling by GPCR—EDN1—type 2 diabetes mellitus	1.76e-05	0.000739	CbGpPWpGaD
Dexbrompheniramine—HRH1—GPCR downstream signaling—CCR5—type 2 diabetes mellitus	1.74e-05	0.000728	CbGpPWpGaD
Dexbrompheniramine—HRH1—GPCR downstream signaling—C3—type 2 diabetes mellitus	1.7e-05	0.000711	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling by GPCR—ADCY5—type 2 diabetes mellitus	1.68e-05	0.000702	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling Pathways—ATP2A2—type 2 diabetes mellitus	1.66e-05	0.000694	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling Pathways—IAPP—type 2 diabetes mellitus	1.65e-05	0.00069	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling Pathways—INSR—type 2 diabetes mellitus	1.64e-05	0.000686	CbGpPWpGaD
Dexbrompheniramine—HRH1—GPCR downstream signaling—AGT—type 2 diabetes mellitus	1.61e-05	0.000676	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling Pathways—TRPC6—type 2 diabetes mellitus	1.61e-05	0.000674	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling by GPCR—PPP2CA—type 2 diabetes mellitus	1.61e-05	0.000673	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling Pathways—AGTR2—type 2 diabetes mellitus	1.6e-05	0.00067	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling by GPCR—CCR5—type 2 diabetes mellitus	1.58e-05	0.000661	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling by GPCR—C3—type 2 diabetes mellitus	1.54e-05	0.000646	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling Pathways—EDNRB—type 2 diabetes mellitus	1.53e-05	0.000642	CbGpPWpGaD
Dexbrompheniramine—HRH1—GPCR downstream signaling—PRKCB—type 2 diabetes mellitus	1.49e-05	0.000624	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling Pathways—PSMD6—type 2 diabetes mellitus	1.49e-05	0.000623	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling Pathways—HTR2C—type 2 diabetes mellitus	1.49e-05	0.000623	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling by GPCR—AGT—type 2 diabetes mellitus	1.46e-05	0.000614	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling Pathways—EDNRA—type 2 diabetes mellitus	1.45e-05	0.000606	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling by GPCR—CALM1—type 2 diabetes mellitus	1.44e-05	0.000603	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling Pathways—CYBA—type 2 diabetes mellitus	1.44e-05	0.000603	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling Pathways—ADRA2A—type 2 diabetes mellitus	1.42e-05	0.000593	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling Pathways—GHRL—type 2 diabetes mellitus	1.41e-05	0.000591	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling Pathways—PLAT—type 2 diabetes mellitus	1.41e-05	0.000591	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling Pathways—CALCA—type 2 diabetes mellitus	1.39e-05	0.000583	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling by GPCR—PRKCB—type 2 diabetes mellitus	1.35e-05	0.000567	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling Pathways—TCF7L2—type 2 diabetes mellitus	1.31e-05	0.000549	CbGpPWpGaD
Dexbrompheniramine—HRH1—GPCR downstream signaling—AKT2—type 2 diabetes mellitus	1.31e-05	0.000547	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling Pathways—PTPN1—type 2 diabetes mellitus	1.29e-05	0.00054	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling Pathways—GCG—type 2 diabetes mellitus	1.29e-05	0.00054	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling Pathways—RASGRP1—type 2 diabetes mellitus	1.27e-05	0.000531	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling Pathways—NOTCH2—type 2 diabetes mellitus	1.26e-05	0.00053	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling by GPCR—CCL2—type 2 diabetes mellitus	1.21e-05	0.000505	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling by GPCR—AKT2—type 2 diabetes mellitus	1.19e-05	0.000497	CbGpPWpGaD
Dexbrompheniramine—HRH1—GPCR downstream signaling—PIK3R1—type 2 diabetes mellitus	1.18e-05	0.000496	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling Pathways—TGFBR2—type 2 diabetes mellitus	1.12e-05	0.00047	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling Pathways—GNB3—type 2 diabetes mellitus	1.11e-05	0.000465	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling Pathways—AVP—type 2 diabetes mellitus	1.1e-05	0.000459	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling Pathways—MMP3—type 2 diabetes mellitus	1.1e-05	0.000459	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling Pathways—IGF2—type 2 diabetes mellitus	1.09e-05	0.000457	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling Pathways—CDKN2B—type 2 diabetes mellitus	1.09e-05	0.000455	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling by GPCR—PIK3R1—type 2 diabetes mellitus	1.08e-05	0.000451	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling Pathways—APOB—type 2 diabetes mellitus	1.06e-05	0.000444	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling Pathways—IGF1R—type 2 diabetes mellitus	1.06e-05	0.000442	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling Pathways—EDN1—type 2 diabetes mellitus	1.04e-05	0.000437	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling Pathways—LPL—type 2 diabetes mellitus	1.01e-05	0.000424	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling Pathways—ADCY5—type 2 diabetes mellitus	9.9e-06	0.000415	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	9.49e-06	0.000398	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling Pathways—CCR5—type 2 diabetes mellitus	9.32e-06	0.00039	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling Pathways—C3—type 2 diabetes mellitus	9.11e-06	0.000382	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling Pathways—HIF1A—type 2 diabetes mellitus	8.69e-06	0.000364	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling Pathways—IRS2—type 2 diabetes mellitus	8.66e-06	0.000363	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling Pathways—AGT—type 2 diabetes mellitus	8.65e-06	0.000363	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling Pathways—CALM1—type 2 diabetes mellitus	8.51e-06	0.000356	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling Pathways—LEP—type 2 diabetes mellitus	8.48e-06	0.000355	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling Pathways—APOE—type 2 diabetes mellitus	8.48e-06	0.000355	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling Pathways—APOA1—type 2 diabetes mellitus	8.38e-06	0.000351	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling Pathways—PRKCB—type 2 diabetes mellitus	8e-06	0.000335	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling Pathways—IRS1—type 2 diabetes mellitus	7.56e-06	0.000317	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling Pathways—INS—type 2 diabetes mellitus	7.24e-06	0.000303	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling Pathways—CCL2—type 2 diabetes mellitus	7.13e-06	0.000299	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling Pathways—IGF1—type 2 diabetes mellitus	7.01e-06	0.000294	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling Pathways—AKT2—type 2 diabetes mellitus	7e-06	0.000293	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling by GPCR—EGFR—type 2 diabetes mellitus	6.97e-06	0.000292	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	6.65e-06	0.000279	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling Pathways—NOS3—type 2 diabetes mellitus	6.35e-06	0.000266	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	6.35e-06	0.000266	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling Pathways—RELA—type 2 diabetes mellitus	5.98e-06	0.000251	CbGpPWpGaD
Dexbrompheniramine—HRH1—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	5.44e-06	0.000228	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling Pathways—CASP3—type 2 diabetes mellitus	5.39e-06	0.000226	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling by GPCR—IL6—type 2 diabetes mellitus	5.36e-06	0.000224	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling Pathways—MMP9—type 2 diabetes mellitus	5.1e-06	0.000214	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling Pathways—NFKB1—type 2 diabetes mellitus	5.04e-06	0.000211	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling by GPCR—AKT1—type 2 diabetes mellitus	4.94e-06	0.000207	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling Pathways—SRC—type 2 diabetes mellitus	4.7e-06	0.000197	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling Pathways—VEGFA—type 2 diabetes mellitus	4.58e-06	0.000192	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling Pathways—TGFB1—type 2 diabetes mellitus	4.2e-06	0.000176	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling Pathways—EGFR—type 2 diabetes mellitus	4.12e-06	0.000173	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling Pathways—IL6—type 2 diabetes mellitus	3.17e-06	0.000133	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling Pathways—AKT1—type 2 diabetes mellitus	2.92e-06	0.000122	CbGpPWpGaD
